RankAlpha logo
Back to Rankings

DBVT

DBVC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
DBVT vs peer average
42/100
DBVT vs. peer average (C vs. B)
Grade spread
A 3 · B 1 · C 4 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

DSGN is the first available peer comparator.

Loose small-cap biotech comparison; different disease focus and development program, so valuation comparability is limited.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerDSGNDesign Therapeutics
DBVT
DBV
DSGN
Design Therapeutics
Grade
C
C
Momentum
10
76
Value
41
41
Sentiment
75
56
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed

Grade position vs DSGN

DBVT / DSGN
Grade Position
Below peers
DBVT vs. peer average (C vs. B)
42/100
Momentum
10
DSGN
Value
41
DBVT
Sentiment
75
DBVT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs DBVT
1
DSGN
DSGN
D
40/100
+1
2
GERN
GERN
C
60/100
Even
3
KURA
KURA
D
40/100
+1
4
ABUS
Arbutus Biopharma Corp Common
B
80/100
-1
5
CADL
Candel Therapeutics Inc Common
A
100/100
-2
DSGN is the first peer returned for this comparison set.